CELUW
Price:
$0.0152
Market Cap:
$51.26M
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic ...[Read more]
Industry
Biotechnology
IPO Date
2021-07-19
Stock Exchange
NASDAQ
Ticker
CELUW
According to Celularity Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -97.91% compared to the average of -0.96 of the last 4 quarters.
The mean historical PE Ratio of Celularity Inc. over the last ten years is -534582.19. The current -0.02 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), CELUW's PE Ratio was at its highest in in the June 2019 quarter at 92.16. The PE Ratio was at its lowest in in the March 2019 quarter at -483375.48.
Average
-534582.19
Median
-2.54
Minimum
-3207536.43
Maximum
40.41
Discovering the peaks and valleys of Celularity Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 31.18%
Maximum Annual PE Ratio = 40.41
Minimum Annual Increase = -325.15%
Minimum Annual PE Ratio = -3207536.43
Year | PE Ratio | Change |
---|---|---|
2023 | -0.22 | -101.56% |
2022 | 14.33 | -325.15% |
2021 | -6.37 | 31.18% |
2020 | -4.85 | -112.01% |
2019 | 40.41 | -100.00% |
The current PE Ratio of Celularity Inc. (CELUW) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.58
5-year avg
8.66
10-year avg
-534582.19
Celularity Inc.’s PE Ratio is greater than Celularity Inc. (-1.43), less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Quantum-Si incorporated (-2.06), greater than Humacyte, Inc. (-3.52), greater than Surrozen, Inc. (-0.89),
Company | PE Ratio | Market cap |
---|---|---|
-1.43 | $51.26M | |
-0.00 | $2.82K | |
-2.06 | $166.64M | |
-3.52 | $238.04M | |
-0.89 | $48.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Celularity Inc.'s PE Ratio?
How is the PE Ratio calculated for Celularity Inc. (CELUW)?
What is the highest PE Ratio for Celularity Inc. (CELUW)?
What is the 3-year average PE Ratio for Celularity Inc. (CELUW)?
What is the 5-year average PE Ratio for Celularity Inc. (CELUW)?
How does the current PE Ratio for Celularity Inc. (CELUW) compare to its historical average?